The use of big data and AI in clinical medicine and biomedical research to guide clinical decisions has become a central aspect of precision medicine initiatives.
During this online event jointly hosted by the West of England AHSN and the University of Bath, Dr David Scheinker from Stanford University will be exploring both their potential promise and the perils. He will explore these themes using a real-life clinical example – the use of decision support software for glucose control for patients with type 1 diabetes.
